# CHIN-WIN Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/chin-win-health

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Latest round: Angel (Sep 28, 2026)
- Investors on record: 4

## About

Based in Jiangsu, China and founded in 2025, Xinyun Life Science Technology (Suzhou) Co., Ltd., trading as CHIN-WIN Health, provides artificial intelligence-enabled neurovascular intervention devices and medical imaging technologies for the neurointerventional healthcare sector. The company was founded by Jun Zhao, who has nearly two decades of experience in cardiovascular and neurovascular intervention industries, including leadership roles at major medical device companies. In September 2026, CHIN-WIN Health raised an Angel+ funding from Delian Capital, Zhongguancun Development Venture and Sanbo Brain Hospital.

CHIN-WIN Health works with hospitals, neurointerventional physicians, research institutions, and medical device providers to develop AI-enabled neurovascular imaging and intervention technologies. Its flagship product is Neuro-IVUS, an intravascular ultrasound diagnostic system designed specifically for neurovascular applications. The platform combines miniaturized ultrasound transducer technology, intelligent image processing, and AI-assisted clinical decision support capabilities. Key functionalities include plaque characterization, stenosis measurement, stent apposition assessment, and real-time vascular imaging during neurointerventional procedures. The company’s AI platform supports automated lesion analysis, quantitative diagnostics, and image-assisted procedural guidance. 

The company's revenue is generated through the commercialization of AI-powered neurovascular imaging systems, intravascular ultrasound platforms, and related software solutions. 

The company will use the Angel+ funding to support the clinical development and registration of its Neuro-IVUS system and advance its ultrasound brain science product portfolio.

## Funding rounds

- Angel, Sep 28, 2026 — Delian Capital, Zhongguancun Development Venture, Sanbo Brain Hospital
- Angel, Aug 24, 2026 — Efung Capital

## Investors

- Efung Capital (https://capitalatlas.ai/funds/efung-capital) — Angel
- Delian Capital (https://capitalatlas.ai/funds/delian-capital) — Angel
- Zhongguancun Development Venture (https://capitalatlas.ai/funds/zhongguancun-development-venture) — Angel
- Sanbo Brain Hospital — Angel